Literature DB >> 19957299

Expression analysis of epithelial cadherin and related proteins in IBH-6 and IBH-4 human breast cancer cell lines.

Lara Lapyckyj1, Lilian Fedra Castillo, María Laura Matos, Nieves María Gabrielli, Isabel Alicia Lüthy, Mónica Hebe Vazquez-Levin.   

Abstract

Epithelial cadherin (E-cadherin) is a 120 kDa cell-cell adhesion molecule involved in the establishment of epithelial adherens junctions. It is connected to the actin cytoskeleton by adaptor proteins such as beta-catenin. Loss of E-cadherin expression/function has been related to tumor progression and metastasis. Several molecules associated with down-regulation of E-cadherin have been described, within them neural cadherin, Twist and dysadherin. Human breast cancer cell lines IBH-6 and IBH-4 were developed from ductal primary tumors and show characteristic features of malignant epithelial cells. In this study expression of E-cadherin and related proteins in IBH-6 and IBH-4 cell lines was evaluated. In IBH-6 and IBH-4 cell extracts, only an 89 kDa E-cadherin form (Ecad89) was detected, which is truncated at the C-terminus and is present at low levels. Moreover, no accumulation of the 86 kDa E-cadherin ectodomain and of the 38 kDa CTF1 fragment was observed. IBH-6 and IBH-4 cells showed an intracellular scattered E-cadherin localization. beta-catenin accompanied E-cadherin localization, and actin stress fibers were identified in both cell types. E-cadherin mRNA levels were remarkably low in IBH-6 and IBH-4 cells. The E-cadherin mRNA and genomic sequence encoding exons 14-16 could not be amplified in either cell line. Neither the mRNA nor the protein of neural cadherin and dysadherin were detected. Up-regulation of Twist mRNA was found in both cell lines. In conclusion, IBH-6 and IBH-4 breast cancer cells show down-regulation of E-cadherin expression with aberrant protein localization, and up-regulation of Twist; these features can be related to their invasive/metastatic characteristics.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19957299     DOI: 10.1002/jcp.21974

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  6 in total

1.  Polymorphisms in the 3'-untranslated region of the CDH1 gene are a risk factor for primary gastric diffuse large B-cell lymphoma.

Authors:  Gunnar Jacobs; Stephan Hellmig; Klaus Huse; Andrea Titz; Andre Franke; Ruta Kwiatkowski; Stephan Ott; Markus Kosmahl; Wolfgang Fischbach; Ralph Lucius; Wolfram Klapper; Ulrich R Fölsch; Jochen Hampe; Stefan Schreiber; Philip Rosenstiel
Journal:  Haematologica       Date:  2011-04-01       Impact factor: 9.941

2.  Fibroblast Growth Factor Receptors (FGFRs) in Human Sperm: Expression, Functionality and Involvement in Motility Regulation.

Authors:  Lucía Saucedo; Gabriela N Buffa; Marina Rosso; Tomás Guillardoy; Adrian Góngora; María J Munuce; Mónica H Vazquez-Levin; Clara Marín-Briggiler
Journal:  PLoS One       Date:  2015-05-13       Impact factor: 3.240

3.  E-cadherin: A determinant molecule associated with ovarian cancer progression, dissemination and aggressiveness.

Authors:  Marina Rosso; Blanca Majem; Laura Devis; Lara Lapyckyj; María José Besso; Marta Llauradó; María Florencia Abascal; María Laura Matos; Lucia Lanau; Josep Castellví; José Luis Sánchez; Asunción Pérez Benavente; Antonio Gil-Moreno; Jaume Reventós; Anna Santamaria Margalef; Marina Rigau; Mónica Hebe Vazquez-Levin
Journal:  PLoS One       Date:  2017-09-21       Impact factor: 3.240

4.  miR-623 suppresses cell proliferation, migration and invasion through direct inhibition of XRCC5 in breast cancer.

Authors:  Qing Li; Jiangtao Liu; Yanli Jia; Tingting Li; Mei Zhang
Journal:  Aging (Albany NY)       Date:  2020-06-05       Impact factor: 5.682

5.  Identification of early stage recurrence endometrial cancer biomarkers using bioinformatics tools.

Authors:  María José Besso; Luciana Montivero; Ezequiel Lacunza; María Cecilia Argibay; Martín Abba; Laura Inés Furlong; Eva Colas; Antonio Gil-Moreno; Jaume Reventos; Ricardo Bello; Mónica Hebe Vazquez-Levin
Journal:  Oncol Rep       Date:  2020-06-16       Impact factor: 3.906

6.  Ephrin-B1 Is a Novel Biomarker of Bladder Cancer Aggressiveness. Studies in Murine Models and in Human Samples.

Authors:  María Victoria Mencucci; Lara Lapyckyj; Marina Rosso; María José Besso; Denise Belgorosky; Mariana Isola; Silvia Vanzulli; Catalina Lodillinsky; Ana María Eiján; Juan Carlos Tejerizo; Matías Ignacio Gonzalez; María Ercilia Zubieta; Mónica Hebe Vazquez-Levin
Journal:  Front Oncol       Date:  2020-03-27       Impact factor: 6.244

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.